Company
Nuvasive
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
32
510(k), De Novo and PMA
Device trials
16
As lead sponsor, any status
Adverse event reports
204
Received Nov 1, 2025 to Nov 19, 2026
Recall records
47
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$0
1 Form D offering, 2011 to 2011
Equity
$0
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $40.5M raised of $40.5M sought, first sale Oct 7, 2011, 9 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 2011 | Equity Issued in a merger or acquisition; not counted as money raised | $40.5M | $40.5M | 9 | Rule 506 | Form D ↗Oct 19, 2011 |
Company details
From the company's latest Form D.
- Legal name
- NUVASIVE INC
- Headquarters
- San Diego, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1142596 ↗
Executives, directors and promoters
As listed on the latest Form D.
12 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Nuvasive.
Latest FDA decisions
The 8 newest of 32 since 2015.
K261651 · Decided Jun 18, 2026 · 30 days after receipt
Device type: Rod, Fixation, Intramedullary And Accessories (HSB) · Orthopedic Surgery
K233706 · Decided Aug 2, 2024 · 256 days after receipt
Device type: Orthopedic Stereotaxic Instrument (OLO) · Neurology & Neurosurgery
- NuVasive AttraX Scaffold510(k)
K240507 · Decided Mar 20, 2024 · 28 days after receipt
Device type: Filler, Bone Void, Calcium Compound (MQV) · Orthopedic Surgery
29 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT02667067 · 150 participants · Start Nov 2015 · Primary completion Mar 23, 2020
Device: Simplify Disc; Anterior Cervical Discectomy & Fusion · For: Cervical Degenerative Disc Disease
Sites: La Jolla, California; Orange, California; Santa Monica, California · 16 sites in all
NCT04630626 · 145 participants · Start Jan 1, 2021 · Primary completion Apr 23, 2023
Device: Simplify Disc · For: Cervical Degenerative Disc Disorder
Sites: Orange, California; San Diego, California; Santa Monica, California · 15 sites in all
NCT03123549 · 182 participants · Start Apr 1, 2017 · Primary completion Nov 12, 2020
Device: Simplify Disc · For: Cervical Degenerative Disc Disorder
Sites: Orange, California; Santa Monica, California; Thornton, Colorado · 18 sites in all
13 more trials with a free account
Reports received
204
Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.
Malfunction reports
151
74% of reports
Injury reports
49
24% of reports
Death reports
1
0.5% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 10 | 12 | 0 | 0 |
| Jan 24 | 23 | 27 | 0 | 0 |
| Feb 24 | 21 | 16 | 1 | 0 |
| Mar 24 | 11 | 14 | 0 | 0 |
| Apr 24 | 24 | 20 | 1 | 0 |
| May 24 | 12 | 9 | 1 | 0 |
| Jun 24 | 15 | 10 | 0 | 1 |
| Jul 24 | 23 | 9 | 0 | 0 |
| Aug 24 | 44 | 17 | 0 | 0 |
| Sep 24 | 19 | 12 | 0 | 0 |
| Oct 24 | 19 | 28 | 0 | 0 |
| Nov 24 | 15 | 15 | 1 | 0 |
| Dec 24 | 27 | 21 | 0 | 0 |
| Jan 25 | 8 | 6 | 0 | 0 |
| Feb 25 | 12 | 12 | 0 | 0 |
| Mar 25 | 14 | 12 | 0 | 0 |
| Apr 25 | 16 | 7 | 0 | 0 |
| May 25 | 13 | 9 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 20 | 0 | 0 | 0 |
| Sep 25 | 19 | 3 | 0 | 0 |
| Oct 25 | 7 | 0 | 0 | 0 |
| Nov 25 | 10 | 1 | 0 | 0 |
| Dec 25 | 25 | 2 | 0 | 0 |
| Jan 26 | 16 | 3 | 0 | 0 |
| Feb 26 | 21 | 3 | 0 | 0 |
| Mar 26 | 13 | 0 | 0 | 0 |
| Apr 26 | 10 | 4 | 0 | 0 |
| May 26 | 17 | 1 | 0 | 0 |
| Jun 26 | 8 | 2 | 0 | 0 |
| Jul 26 | 8 | 2 | 0 | 0 |
| Aug 26 | 7 | 12 | 0 | 2 |
| Sep 26 | 11 | 9 | 0 | 0 |
| Oct 26 | 5 | 10 | 1 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- RELINE59
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0500-2025 · Started Sep 30, 2024 · Posted by FDA Nov 21, 2024
Reason given: Due to potential issues with design, manufacturing and documentation issues related to the validation of the affected products/devices.
Cause as FDA categorized it: Under Investigation by firm · Device type: Rod, Fixation, Intramedullary And Accessories (HSB)
- X-CORE 2 Ti Core, Static. Part of the NuVasive X-Core Expandable VBR System used with spinal fixation.Open, Classified
Z-0738-2023 · Started Nov 10, 2022 · Posted by FDA Dec 20, 2022
Reason given: Potential that insert will be unable to disengage from the vertebral body replacement device/implant
Cause as FDA categorized it: Device Design · Device type: Spinal Vertebral Body Replacement Device (MQP)
Z-0559-2023 · Started Nov 1, 2022 · Posted by FDA Dec 14, 2022
Reason given: During accelerated shelf-life extension studies it was noted that the final packaging was experiencing a potential of failure of the sterile packaging barrier which could result in a hazardous situation where the device is no longer sterile.
Cause as FDA categorized it: Process control · Device type: Growing Rod System- Magnetic Actuation (PGN)
44 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.